Lilly And Novo Nordisk Shape Up For Obesity Treatment Battle Of The Heavyweights

Key Phase III Readouts Soon

 
• By Andrew McConaghie
Eli Lilly logo sign atop Lilly Biotechnology Center
Lilly's drug outperformed Novo's in a head-to-head in diabetes, but is now aiming for superiority in obesity treatment as well. • Source: Michael Vi / Shutterstock.com

More from Business

More from Scrip